Susquehanna International Group, LLP Amgen Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Amgen Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 189,515 shares of AMGN stock, worth $52.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

189,515

Previous 202,156 6.25%

Holding current value

$52.2 Million

Previous $63.2 Million 3.32%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $3.91 Million - $4.26 Million	-12,641 Reduced 6.25%	189,515 $61.1 Million
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $5.4 Million - $6.57 Million	20,560 Added 11.32%	202,156 $63.2 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $33.8 Million - $40.7 Million	-125,546 Reduced 40.88%	181,596 $51.6 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $40.2 Million - $45.3 Million	-157,073 Reduced 33.84%	307,142 $88.5 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $31.8 Million - $39.4 Million	-145,302 Reduced 23.84%	464,215 $125 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $32.9 Million - $38.9 Million	153,606 Added 33.69%	609,517 $135 Million
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $36.8 Million - $44.8 Million	162,908 Added 55.6%	455,911 $110 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $20.5 Million - $26 Million	89,362 Added 43.88%	293,003 $77 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $57.5 Million - $64.8 Million	-256,051 Reduced 55.7%	203,641 $45.9 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $28.1 Million - $31.3 Million	121,809 Added 36.05%	459,692 $112 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $14.9 Million - $16.5 Million	67,880 Added 25.14%	337,883 $81.7 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $3.16 Million - $3.62 Million	-15,910 Reduced 5.56%	270,003 $60.7 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $57,312 - $67,149	-270 Reduced 0.09%	285,913 $60.8 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $46.1 Million - $51.2 Million	197,390 Added 222.3%	286,183 $69.8 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $26.4 Million - $30.8 Million	-118,997 Reduced 57.27%	88,793 $22.1 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $36 Million - $42.9 Million	166,381 Added 401.8%	207,790 $47.8 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $36 Million - $40.1 Million	-153,491 Reduced 78.75%	41,409 $10.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $10.5 Million - $12.9 Million	-53,046 Reduced 21.39%	194,900 $46 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $34 Million - $45.1 Million	-186,746 Reduced 42.96%	247,946 $50.3 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $58.5 Million - $75.1 Million	308,961 Added 245.73%	434,692 $105 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $24.4 Million - $29.2 Million	-139,922 Reduced 52.67%	125,731 $24.3 Million
Q2 2019 Aug 16, 2019	BUY	$166.7 - $195.41 $32.9 Million - $38.6 Million	197,515 Added 289.87%	265,653 $49 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $1.54 Million - $1.81 Million	-9,251 Reduced 11.95%	68,138 $12.6 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $2.41 Million - $2.72 Million	-13,025 Reduced 14.41%	77,389 $16 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.64 Million - $2.97 Million	15,902 Added 21.34%	90,414 $16.7 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $43.2 Million - $50.5 Million	-255,225 Reduced 77.4%	74,512 $12.7 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $38.7 Million - $43.2 Million	228,989 Added 227.29%	329,737 $57.3 Million
Q3 2017 Nov 20, 2017	BUY	$167.29 - $191.0 $16.9 Million - $19.2 Million	100,748	100,748 $18.8 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Amgen Inc Transaction History